Authors

  • Хамраев А.А., Нуритдинов Н.А., Гадаева Н.А., Агзамходжаева С.С., Пирматова Н.В.

Keywords:

alkogolsiz yog’li jigar kasalligi, gen ekspressiyasi, LRP1, LDLR, LOX1, jigar steatozi, Yang moduli, FLI.

References

1. Actis Dato V, Chiabrando GA. The role of low-density lipo- protein receptor-related protein 1 in lipid metabolism, glucose homeostasis and inflammation. Int J Mol Sci.2019;20(3):528.

2. Butcovan D et al. Macrophage accumulation and angio- genesis in epicardial adipose tissue in cardiac patients with or without chronic heart failure. Appl. Sci.2020;10:5871.

3. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Me- tabolism.2016;65:1038-48.

4. Chalasani N et al. The diagnosis and management of non-alcoholic fatty liver disease: Practice guidance from the AASLD. Hepatology.2018;67(1):328-57.

5. Iacobellis G, Mahabadi AA. Is epicardial fat attenuation a novel marker of coronary inflammation? Atherosclero- sis.2019;284:212-3.

6. Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fat- ty liver disease. Cell Mol Life Sci. 2018;75:3313-27.

7. Sasaki A, Nitta H, Otsuka K et al. Vilstric surgery and non-alcoholic fatty liver disease: current and potential future treatments. Front Endocrinol. 2014;5:164.

8. Xian YX, Weng JP, Xu F. MAFLD vs. NAFLD: shared features and potential changes in epidemiology, pathophysiology, diag- nosis, and pharmacotherapy. Chin Med J.2020;134:8-19.

9. Younossi ZM et al. Global epidemiology of nonalcoholic fatty liver disease. Hepatology.2016;64(1):73-84.